DAPAFORD M
(Dapagliflozin + Metformin)
Dual Glycemic + Renal Protection Therapy
PRODUCT INTRODUCTION
Brand Name: DAPAFORD M
Composition:
- Dapagliflozin
- Metformin
Category: Combination OHA with Renal Benefit
CLINICAL BACKGROUND
Most Type 2 Diabetes patients:
- Start on Metformin
- Develop progressive renal risk
- Require additional renal protection
👉 DAPAFORD M combines glycemic base therapy + nephroprotection.
MODE OF ACTION
Metformin:
- Reduces hepatic glucose production
- Improves insulin sensitivity
Dapagliflozin:
- Reduces glucose reabsorption
- Protects kidney via hemodynamic mechanism
Combined Benefit:
✔ Strong HbA1c reduction
✔ Renal protection
✔ CV risk reduction
INDICATIONS
- Type 2 Diabetes uncontrolled on Metformin
- Diabetic nephropathy
- Albuminuria
- Obese diabetic patients
DOSAGE
As prescribed
Usually once or twice daily depending on strength
FAB
🔹 Feature
Dual combination tablet
🔹 Advantage
Glycemic + Renal + CV protection
🔹 Benefit
Comprehensive diabetes management
USP
✔ Single tablet compliance
✔ Renal-protective add-on
✔ Weight neutral to reducing
✔ Cardiometabolic benefit
SAFETY PROFILE
- Monitor renal function
- Watch for UTI
- Avoid in severe renal failure
- Metformin contraindicated in advanced renal impairment
TORGIVE 10 / 20
(Torsemide 10 mg / 20 mg)
Advanced Loop Diuretic Therapy for Cardio–Renal Patients
PRODUCT INTRODUCTION
Brand Name: TORGIVE 10 / 20
Composition: Torsemide 10 mg / 20 mg
Category: Loop Diuretic
CLINICAL BACKGROUND (FOR MR UNDERSTANDING)
In CKD & Heart Failure patients:
- Fluid retention common
- Peripheral edema
- Pulmonary congestion
- Hypertension worsens
- Cardiac workload increases
👉 Proper diuresis improves outcomes.
Compared to Furosemide, Torsemide offers:
- Better oral bioavailability
- Longer duration
- More predictable effect
MODE OF ACTION (MOA)
- Acts on Thick Ascending Limb of Loop of Henle
- Inhibits Na⁺/K⁺/2Cl⁻ transporter
- Promotes sodium & water excretion
- Reduces preload & afterload
Clinical Effects:
✔ Reduces edema
✔ Lowers blood pressure
✔ Improves heart failure symptoms
✔ Decreases fluid overload in CKD
INDICATIONS
- Congestive Heart Failure
- CKD with fluid overload
- Nephrotic syndrome
- Resistant hypertension
- Peripheral edema
DOSAGE
- TORGIVE 10 mg – Mild to moderate edema
- TORGIVE 20 mg – Severe edema / CHF
Once daily dosing preferred
As directed by physician
FEATURE – ADVANTAGE – BENEFIT (FAB)
🔹 Feature
High oral bioavailability loop diuretic
🔹 Advantage
More predictable diuretic response vs furosemide
🔹 Benefit
Better symptom control & fewer hospitalizations
USP
✔ Longer duration of action
✔ Better absorption than furosemide
✔ Effective in CKD fluid overload
✔ Once daily convenience
✔ Useful in resistant edema
SAFETY PROFILE
- Hypokalemia
- Hypotension
- Dehydration
- Monitor electrolytes
- Use cautiously in severe renal impairment
